Revance Therapeutics (NASDAQ:RVNC) plunged 16% in after hours trading after the company disclosed that there's substantial doubt about its ability to contine as a "going concern." The company also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback